Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

about

Pharmacokinetic/Pharmacodynamic Modeling of the PDE4 Inhibitor TAK-648 in Type 2 Diabetes: Early Translational Approaches for Human Dose Prediction Avibactam Pharmacokinetic/Pharmacodynamic Targets.

P2860

Q33648004-F108A26A-F2D4-444B-A945-82C9E249D43C Q52611981-4D0215DB-22A1-406D-9295-01D596FFA776

P2860

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

Item

http://www.wikidata.org/entity/Q40606599

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

@en

type

Item

label

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

@en

prefLabel

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

@en

P1476

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

@en

P2093

A Lundahl

http://www.w3.org/2001/XMLSchema#string

M B Någård

http://www.w3.org/2001/XMLSchema#string

M Sundqvist

http://www.w3.org/2001/XMLSchema#string

P Gennemark

http://www.w3.org/2001/XMLSchema#string

U Bredberg

http://www.w3.org/2001/XMLSchema#string

P2860

Visualizing uncertainty about the future

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

A general model for the origin of allometric scaling laws in biology

Allometric scaling of xenobiotic clearance: uncertainty versus universality

To scale or not to scale: the principles of dose extrapolation

Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 1: volume of distribution at steady state.

Comprehensive assessment of human pharmacokinetic prediction based on in vivo animal pharmacokinetic data, part 2: clearance.

Drug-like properties and the causes of poor solubility and poor permeability.

Automated analysis of routinely generated preclinical pharmacokinetic and pharmacodynamic data.

Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches.

P304

243-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PSP4.32

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275103294

http://www.w3.org/2001/XMLSchema#string

P698

26225248

http://www.w3.org/2001/XMLSchema#string

P932

4429578

http://www.w3.org/2001/XMLSchema#string

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

about

P2860

P2860

Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932